Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.
Investors seeking stability in volatile markets often turn to consumer staples ETFs. We analyze the strategic divergence between Fidelity's broad, low-cost approach and Invesco's targeted, factor-driven fund to determine which might better serve a defensive portfolio.
Simon Property Group reported robust fourth-quarter results, driven by record funds from operations and resilient leasing demand. The retail REIT giant is steering a multi-billion dollar redevelopment strategy while returning significant capital to shareholders, even as it navigates a cautious outlook for 2026.
Simon Property Group reported robust fourth-quarter and full-year 2025 results, highlighted by record funds from operations, $2 billion in strategic acquisitions, and a significant return of capital to shareholders. The retail REIT giant provided optimistic 2026 guidance, banking on a strong development pipeline and resilient tenant demand despite acknowledging tariff-related headwinds.
Saks Global is closing most of its Saks OFF 5TH off-price stores across the U.S., leaving only a dozen locations open as it refocuses on core luxury and full-price retail after a recent Chapter 11 filing.
GameStop has transferred its entire Bitcoin holdings to an institutional exchange, as CEO Ryan Cohen pivots the company's focus toward a major acquisition, suggesting its crypto strategy is being deprioritized.
U.S.-listed exchange-traded funds attracted $165.4 billion in January, with a notable pivot toward international stock funds as they continue to outperform domestic markets.
As large-cap stocks dominate headlines, a search for value turns to Asia's smaller players. We examine three companies—from logistics to tech to construction—that combine strong fundamentals with compelling valuations, offering potential for investors looking beyond the index giants.
As investors seek reliable cash flow in a volatile market, a focus on assets with strong distribution histories and growth potential remains key. Here’s a look at three income-generating investments poised for steady returns.
Despite a 22.9% rally over the past year, new analysis suggests Julius Bär Gruppe shares may still be trading at a significant discount to their intrinsic value, presenting a potential opportunity for value-focused investors.
Alphabet's self-driving subsidiary Waymo has closed a massive $16 billion funding round, catapulting its valuation to $126 billion and signaling robust investor confidence in the future of autonomous vehicles.
As Alphabet prepares to report its fourth-quarter results, traders are bracing for significant stock movement. The focus is on whether strong performance in cloud and AI can justify its recent surge and sustain momentum amid heightened investor scrutiny.
Powersports giant Polaris unveils an industry-first active suspension system in its flagship RZR, alongside approving its 31st consecutive annual dividend increase, signaling a dual focus on innovation and shareholder returns amid portfolio restructuring.
In a detailed business update, Plug Power's CEO Andy Marsh made a direct appeal to shareholders to approve an increase in authorized shares, framing it as essential for meeting financial obligations and funding future growth. He warned that failure to pass the proposal would force the company to pursue a reverse stock split—a move he believes historically damages shareholder value.
While the S&P 500 remains a core holding for many, actively managed and thematic ETFs offer a path to potentially superior returns. We analyze three Fidelity funds with distinct strategies—from U.S. tech dominance to international dividend income—that have historically beaten the market.
Abbott Laboratories moves to acquire cancer-testing leader Exact Sciences in a landmark deal, signaling a strategic shift toward high-growth diagnostics while simultaneously restructuring its challenged Nutrition business.
Despite both tech giants aggressively investing in AI, their stock prices are telling divergent stories. We examine the underlying fundamentals that make them resilient picks for any portfolio, regardless of short-term volatility.
Amid subscription fatigue and market fragmentation, the proposed union of Netflix and Warner Bros. Discovery is framed not as a threat to competition, but as a necessary consolidation to compete with tech giants and refocus value on consumers.
Despite a significant weekly drop in market valuation, G Mining Ventures' substantial institutional ownership and strong yearly returns suggest major investors are focused on the long game, even as recent volatility raises questions.
With interest rate uncertainty and global headwinds buffeting markets, income-focused investors are turning to dividend-paying stocks for potential stability. We examine three ASX-listed companies offering yields above 3%, assessing their resilience in the current climate.
